X0306 4 2021-06-03 false 0001636422 Health Catalyst, Inc. HCAT 0001780980 Burton Daniel D. C/O HEALTH CATALYST, INC. 10897 SOUTH RIVER FRONT PARKWAY, #300 SOUTH JORDAN UT 84095 true true false false Chief Executive Officer Common Stock 2021-06-03 4 M false 78871.00 10.80 A 362063.00 D Common Stock 2021-06-03 4 S false 75971.00 52.7924 D 286092.00 D Common Stock 2021-06-03 4 S false 2900.00 53.2185 D 283192.00 D Common Stock 2021-06-04 4 M false 73326.00 10.80 A 356518.00 D Common Stock 2021-06-04 4 M false 19175.00 15.84 A 375693.00 D Common Stock 2021-06-04 4 S false 92501.00 53.0074 D 283192.00 D Stock Option (Right to Buy) 10.80 2021-06-03 4 M false 78871.00 0.00 D 2028-09-27 Common Stock 78871.00 327943.00 D Stock Option (Right to Buy) 15.84 2021-06-04 4 M false 19175.00 0.00 D 2029-02-05 Common Stock 19175.00 165006.00 D Stock Option (Right to Buy) 10.80 2021-06-04 4 M false 73326.00 0.00 D 2028-09-27 Common Stock 73326.00 254617.00 D The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 4, 2021, in accordance with Rule 10b5-1. Represents the weighted average sale price of the shares sold ranging from $52.08 to $53.06 per share, inclusive. Represents the weighted average sale price of the shares sold ranging from $53.08 to $53.57 per share, inclusive. Represents the weighted average sale price of the shares sold ranging from $52.54 to $53.25 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) though (4). 25% of the 747,223 shares underlying the option vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. 25% of the 299,748 shares underlying the option vested in an annual installment on February 5, 2020 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023. /s/ Daniel Orenstein, as Attorney-in-Fact 2021-06-07